MORRISON SCOTT W exercised options at TARSUS PHARMACEUTICALS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 6/16/2025ACC: 0001819790-25-000090
Director
Since Oct 2022
+7.49K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
10.84K acquired · 3.35K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+3.35K
Price / share
—
Trade value
—
% of position
New position
6/13/2025
0.00→3.35K
Total
Net shares
+3.35K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/13/2025 | M · Option Exercise | +3.35K | — | — | New position | 0.00 | 3.35K |
| Total | +3.35K | $0.00 | ||||||
Derivative Transactions3
Stock Option (right to buy)
Direct
Converts to
Common Stock
4.54K shares
Shares
+4.54K
Strike price
40.95
Held after
4.54K
Exercisable
—
6/12/2025
Restricted Stock Units
Direct
Converts to
Common Stock
2.95K shares
Shares
+2.95K
Strike price
Held after
2.95K
Exercisable
—
6/12/2025
Restricted Stock Units
Direct
Converts to
Common Stock
3.35K shares
Shares
−3.35K
Strike price
Held after
0.00
Exercisable
—
6/13/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock4.54K shares | 6/12/2025 | A · Award | +4.54K | 40.95 | — | 4.54K |
| Restricted Stock Units Direct | Common Stock2.95K shares | 6/12/2025 | A · Award | +2.95K | — | 2.95K | |
| Restricted Stock Units Direct | Common Stock3.35K shares | 6/13/2025 | M · Option Exercise | −3.35K | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned6.02K
Total
6.02K indirect6.02K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 6.02K | Indirect |
| Total | 6.02K | 6.02K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported